Hyphens Pharma International Ltd
SGX:1J5
Hyphens Pharma International Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.265
0.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Hyphens Pharma International Ltd hold over its rivals?
What risks and challenges
does Hyphens Pharma International Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Hyphens Pharma International Ltd.
Provide an overview of the primary business activities
of Hyphens Pharma International Ltd.
What unique competitive advantages
does Hyphens Pharma International Ltd hold over its rivals?
What risks and challenges
does Hyphens Pharma International Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Hyphens Pharma International Ltd.
Provide P/S
for Hyphens Pharma International Ltd.
Provide P/E
for Hyphens Pharma International Ltd.
Provide P/OCF
for Hyphens Pharma International Ltd.
Provide P/FCFE
for Hyphens Pharma International Ltd.
Provide P/B
for Hyphens Pharma International Ltd.
Provide EV/S
for Hyphens Pharma International Ltd.
Provide EV/GP
for Hyphens Pharma International Ltd.
Provide EV/EBITDA
for Hyphens Pharma International Ltd.
Provide EV/EBIT
for Hyphens Pharma International Ltd.
Provide EV/OCF
for Hyphens Pharma International Ltd.
Provide EV/FCFF
for Hyphens Pharma International Ltd.
Provide EV/IC
for Hyphens Pharma International Ltd.
Show me price targets
for Hyphens Pharma International Ltd made by professional analysts.
What are the Revenue projections
for Hyphens Pharma International Ltd?
How accurate were the past Revenue estimates
for Hyphens Pharma International Ltd?
What are the Net Income projections
for Hyphens Pharma International Ltd?
How accurate were the past Net Income estimates
for Hyphens Pharma International Ltd?
What are the EPS projections
for Hyphens Pharma International Ltd?
How accurate were the past EPS estimates
for Hyphens Pharma International Ltd?
What are the EBIT projections
for Hyphens Pharma International Ltd?
How accurate were the past EBIT estimates
for Hyphens Pharma International Ltd?
Compare the revenue forecasts
for Hyphens Pharma International Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Hyphens Pharma International Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Hyphens Pharma International Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Hyphens Pharma International Ltd compared to its peers.
Compare the P/E ratios
of Hyphens Pharma International Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Hyphens Pharma International Ltd with its peers.
Analyze the financial leverage
of Hyphens Pharma International Ltd compared to its main competitors.
Show all profitability ratios
for Hyphens Pharma International Ltd.
Provide ROE
for Hyphens Pharma International Ltd.
Provide ROA
for Hyphens Pharma International Ltd.
Provide ROIC
for Hyphens Pharma International Ltd.
Provide ROCE
for Hyphens Pharma International Ltd.
Provide Gross Margin
for Hyphens Pharma International Ltd.
Provide Operating Margin
for Hyphens Pharma International Ltd.
Provide Net Margin
for Hyphens Pharma International Ltd.
Provide FCF Margin
for Hyphens Pharma International Ltd.
Show all solvency ratios
for Hyphens Pharma International Ltd.
Provide D/E Ratio
for Hyphens Pharma International Ltd.
Provide D/A Ratio
for Hyphens Pharma International Ltd.
Provide Interest Coverage Ratio
for Hyphens Pharma International Ltd.
Provide Altman Z-Score Ratio
for Hyphens Pharma International Ltd.
Provide Quick Ratio
for Hyphens Pharma International Ltd.
Provide Current Ratio
for Hyphens Pharma International Ltd.
Provide Cash Ratio
for Hyphens Pharma International Ltd.
What is the historical Revenue growth
over the last 5 years for Hyphens Pharma International Ltd?
What is the historical Net Income growth
over the last 5 years for Hyphens Pharma International Ltd?
What is the current Free Cash Flow
of Hyphens Pharma International Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Hyphens Pharma International Ltd.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
SG |
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
88m SGD | 8.6 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD | 73.6 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD | 28 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 20.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF | 20.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP | 32.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD | 13.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF | 19 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | -57.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD | 17.8 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
SG |
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Average P/E:
26
8.6
|
13%
|
0.7 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
73.6
|
49%
|
1.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
Negative Multiple: -15 783.5 | N/A | N/A |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
28
|
26%
|
1.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
20.8
|
19%
|
1.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
20.6
|
16%
|
1.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
32.6
|
36%
|
0.9 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
13.2
|
18%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
19
|
16%
|
1.2 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
Negative Multiple: -57.3 | N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
17.8
|
29%
|
0.6 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.